Automated screening system for identifying SMA and SCID from a dried blood spot

Summary

The tender concerns a complete solution for newborn screening of severe combined immunodeficiency (SCID), X-linked agammaglobulinemia and spinal muscular atrophy (SMA), including DNA extraction. It is a supply contract with an estimated value of EUR 678,776.55. The award criterion is the lowest total price including VAT. The tender is submitted electronically by 11 June 2026 at 08:00, and the contract period is 24 months. Precise exclusion, qualification and compliance requirements must be checked in the tender documents.